Response

Hypertension

Volumn 46, Issue 2, 2005, Pages

  Fyhrquist, Frej ^a   Devereux, Richard B ^b   Kjeldsen, Sverre E ^c   Dahlöf, Björn ^d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745964903     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.0000179215.13289.55     Document Type: Letter

References (5)

1. Safar ME, O'Rourke MF. Pulse pressure and antihypertensive agents. Hypertension. 2005;46:e2.
2. Fyhrquist F, Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Hille DA, Lyle PA, Edelman JM, Snapinn SM, Wedel H; LIFE Study Group. Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy. Hypertension. 2005;45:580-585.
3. Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004; 17:118-123.
4. de Luca N, Asmar RG, London GM, O'Rourke MF, Safar ME; REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens. 2004;22:1623-1630.
5. Hirata K, Vlachopoulos C, Adji A, O'Rourke MF. Benefits from angiotensin-converting enzyme inhibitor "beyond blood pressure lowering": beyond blood pressure of beyond the brachial artery? J Hypertens. 2005; 23:551-556.